Medicinal mining of the microbial biodiversity

Nosopharm is a young innovative biotech company dedicated to the medicinal mining of the microbial biodiversity.

Nosopharm has developed a unique expertise in the screening and the characterization of bioactive secondary metabolites produced by an original microbial bioresource: the bacterial genera Xenorhabdus and Photorhabdus.

This innovative know-how allows Nosopharm to discover and develop novel antibiotic classes for the treatment of multiresistant bacterial infections.